BRIEF published on 07/15/2026 at 17:50, 21 days 14 hours ago Median Technologies Reports on Liquidity Contract for H1 2026 Liquidity Contract Financial Resources Share Transactions Median Technologies H1 2026
PRESS RELEASE published on 07/15/2026 at 17:45, 21 days 14 hours ago Acquisition or disposal of the issuer's own shares / Information relating to the liquidity contract Median Technologies liquidity contract statement for the first half of 2026 reveals resources in the account and transactions made. TP ICAP (Europe) manages the liquidity contract Liquidity Contract Transactions TP ICAP Median Technologies First Half 2026
BRIEF published on 07/03/2026 at 07:05, 1 month 3 days ago Median Technologies' eyonis® LCS receives CE marking Artificial Intelligence Cancer Screening Median Technologies CE Marking Eyonis® LCS
BRIEF published on 07/03/2026 at 07:05, 1 month 3 days ago Median Technologies’ eyonis® LCS Secures CE Marking Early Detection CE Marking European Union Lung Cancer Screening AI-based Diagnostics
PRESS RELEASE published on 07/03/2026 at 07:00, 1 month 3 days ago Inside Information / Other news releases Median Technologies' eyonis® LCS obtains CE Marking under new European Medical Device Regulation, enabling commercial launch across the EU. AI-based software empowers lung cancer screening programs for earlier diagnosis Median Technologies CE Marking AI-based Software Lung Cancer Screening Eyonis® LCS
BRIEF published on 06/03/2026 at 19:59, 2 months 2 days ago Median Technologies Raises €50 Million in Capital Increase Capital Increase Shareholder Base Market Oversubscription Eyonis® Deployment AI-based Diagnostics
PRESS RELEASE published on 06/03/2026 at 19:54, 2 months 2 days ago Inside Information / Other news releases Median Technologies successfully completes €50 million capital increase without shareholders' preferential subscription rights. Funds to deploy eyonis® LCS in U.S. and Europe and expand clinical indications Investment Capital Increase Median Technologies Eyonis® LCS Clinical Indications
BRIEF published on 05/21/2026 at 17:50, 2 months 15 days ago Median Technologies Publishes Shareholder Meeting Documents Voting Rights Shareholders’ Meeting Euronext Growth Median Technologies Documents Availability
PRESS RELEASE published on 05/21/2026 at 17:45, 2 months 15 days ago Terms of availability of the information and the report on corporate governance Median Technologies releases preparatory documents for the Annual Shareholders’ Meeting on June 10, 2026. Shareholders can access documents on the company's website Shareholders General Meeting Annual Shareholders’ Meeting Preparatory Documents Median Technologies
BRIEF published on 03/30/2026 at 15:19, 4 months 6 days ago Median Technologies Achieves ISO 13485:2016 Certification ISO 13485:2016 Regulatory Standards Oncology Solutions Eyonis® AI-based SaMD
Published on 08/06/2026 at 08:05, 32 minutes ago Tocvan Drills Significant Discovery On Mezquite Trend Gran Pilar 215M Of 0.6 G/T AU, From 36.6M Downhole
Published on 08/06/2026 at 03:35, 5 hours 2 minutes ago Tunkillia Upgrade Drilling – 39,000m Phase 2 Complete Targeting JORC Resource Classification Upgrades; PFS Underway
Published on 08/06/2026 at 01:40, 6 hours 57 minutes ago Taranis Identifies a Hydrothermally Altered, Sulfide-Bearing Intrusive Stock Associated with Historic Gold-Silver Occurrence and Connected to Thor
Published on 08/05/2026 at 23:40, 8 hours 57 minutes ago Galantas Gold Secures Key Permitting Approvals for Andacollo Gold Project
Published on 08/05/2026 at 23:10, 9 hours 27 minutes ago Ur-Energy Announces Date for Second Quarter 2026 Results and Conference Call and Webcast
Published on 08/06/2026 at 08:05, 31 minutes ago Norlase Expands European Footprint with Direct Commercial Operations in Germany
Published on 08/06/2026 at 08:00, 36 minutes ago Partners Group enters into exclusive talks to acquire Aroma-Zone, one of the fastest-growing natural beauty and wellness brands in Europe
Published on 08/06/2026 at 08:00, 37 minutes ago 11880 Solutions AG: EBITDA up by 82 per cent in the first half of 2026
Published on 08/06/2026 at 08:00, 37 minutes ago Pentixapharm Reports Second Quarter and First Half 2026 Results and Advances Phase 3 Panda Program
Published on 08/06/2026 at 08:00, 37 minutes ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 14 hours 37 minutes ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 14 hours 47 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 14 hours 52 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 14 hours 52 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
